161 related articles for article (PubMed ID: 31320391)
1. Joint ENGOT and GOG Foundation requirements for trials with industry partners.
Vergote I; Coleman RL; Pignata S; Bookman MA; Marth C; Herzog TJ; Gonzalez Martin A; Copeland LJ;
Int J Gynecol Cancer; 2019 Sep; 29(7):1094-1097. PubMed ID: 31320391
[No Abstract] [Full Text] [Related]
2. Joint ENGOT and GOG Foundation requirements for trials with industry partners.
Vergote I; Coleman RL; Pignata S; Bookman MA; Marth C; Herzog TJ; Gonzalez-Martin A; Copeland LJ; ;
Gynecol Oncol; 2019 Aug; 154(2):255-258. PubMed ID: 31331494
[No Abstract] [Full Text] [Related]
3. The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundation.
Monk BJ; Coleman RL; Herzog TJ; Moore KN; O'Malley DM; Randall LM; Slomovitz BM; Eskander R; Pothuri B; Reese LL; Mannel RS; Copeland LJ
Gynecol Oncol; 2021 Jul; 162(1):203-209. PubMed ID: 33722417
[TBL] [Abstract][Full Text] [Related]
4. European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners--First Update 2015.
du Bois A; Reuss A; Pujade-Lauraine E; Pignata S; Ledermann J; Casado A; Sehouli J; Mirza M; Colombo N; Marth C; Witteveen E; Del Campo J; Calvert P; Aravantinos G; Vardar MA; van der Zee AG; Korach J; Taskiran C; Fehr M; Glasspool R; Pfisterer J; Cibula D; Vergote I;
Int J Gynecol Cancer; 2015 Sep; 25(7):1328-30. PubMed ID: 26067859
[TBL] [Abstract][Full Text] [Related]
5. Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice.
Rimel BJ; Burke WM; Higgins RV; Lee PS; Lutman CV; Parker L
Gynecol Oncol; 2015 May; 137(2):280-4. PubMed ID: 25735256
[TBL] [Abstract][Full Text] [Related]
6. Quality indicators in gynecologic oncology.
Dowdy SC; Cliby WA; Famuyide AO
Gynecol Oncol; 2018 Nov; 151(2):366-373. PubMed ID: 30220409
[No Abstract] [Full Text] [Related]
7. What constitutes the "optimal" treatment environment of women with gynecologic cancer?
Orr JW
Gynecol Oncol; 2003 Apr; 89(1):1-3. PubMed ID: 12694646
[No Abstract] [Full Text] [Related]
8. The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations.
Cohn DE; Ko E; Meyer LA; Wright JD; Temkin SM; Foote J; Jones NL; Havrilesky LJ
Gynecol Oncol; 2017 Apr; 145(1):185-191. PubMed ID: 28258763
[No Abstract] [Full Text] [Related]
9. Society of Gynecologic Oncology meeting highlights progress.
Jenks S
J Natl Cancer Inst; 2011 Apr; 103(7):533-4. PubMed ID: 21436060
[No Abstract] [Full Text] [Related]
10. Trial and error.
Printz C
Cancer; 2013 Feb; 119(3):471-2. PubMed ID: 23341304
[No Abstract] [Full Text] [Related]
11. Gynecologic oncology as a specialty. Current status.
Bõsze P
Eur J Gynaecol Oncol; 1996; 17(2):91-5. PubMed ID: 8654475
[No Abstract] [Full Text] [Related]
12. The oncology care model and the future of alternative payment models: A gynecologic oncology perspective.
Aviki EM; Schleicher SM; Boyd L; Liang M; Ko EM; Zanotti K; Moss H
Gynecol Oncol; 2021 Sep; 162(3):529-531. PubMed ID: 34294415
[No Abstract] [Full Text] [Related]
13. Assessing health-related quality of life in gynecologic oncology.
Nordin AJ; Greimel E;
Int J Gynecol Cancer; 2010 Nov; 20(8):1301. PubMed ID: 21051967
[No Abstract] [Full Text] [Related]
14. Health Services Research: Not just retrospective chart reviews.
Havrilesky L; Rauh-Hain JA
Gynecol Oncol; 2019 Mar; 152(3):437-438. PubMed ID: 30876485
[No Abstract] [Full Text] [Related]
15. Key clinical trials in gynaecological oncology.
Morrison J; Kehoe S
Eur J Surg Oncol; 2006 Oct; 32(8):887-91. PubMed ID: 16677796
[TBL] [Abstract][Full Text] [Related]
16. Roadmap for the European Network of Gynaecological Trial groups (ENGOT) Trials.
Vergote I; Elser G; Votan B; Farrelly L; De Roover J; Bryce J; du Bois A;
Int J Gynecol Cancer; 2013 Sep; 23(7):1339-43. PubMed ID: 23970159
[TBL] [Abstract][Full Text] [Related]
17. European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies.
Vergote I; Pujade-Lauraine E; Pignata S; Kristensen GB; Ledermann J; Casado A; Sehouli J; Mirza M; Fossati R; Marth C; Creutzberg C; Del Campo J; Siddiqui N; Calvert P; Bamias A; Tulunay G; van der Zee AG; du Bois A;
Int J Gynecol Cancer; 2010 Apr; 20(3):476-8. PubMed ID: 20375816
[No Abstract] [Full Text] [Related]
18. Gynecologic Oncology Group (GOG) Report.
Alvarez RD
Gynecol Oncol; 2010 Nov; 119(2):181-2. PubMed ID: 20719372
[No Abstract] [Full Text] [Related]
19. Academic versus industry-driven research in upper gastrointestinal cancer: sinners and saints.
Hendlisz A; Charette N; Awada A; Deleporte A
Curr Opin Oncol; 2013 Jul; 25(4):407-8. PubMed ID: 23673411
[No Abstract] [Full Text] [Related]
20. Clinical Centers of Excellence. Gynecologic oncology. Duke University Medical Center.
Aungst H
Med Econ; 2009 Feb; 86(4):24. PubMed ID: 19405372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
